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This paper describes recent progress made in the use of high pressure or supercritical
ﬂuids to process polymers into three-dimensional tissue engineering scaffolds. Three
current examples are highlighted: foaming of acrylates for use in cartilage tissue
engineering; plasticization and encapsulation of bioactive species into biodegradable
polyesters for bone tissue engineering; and a novel laser sintering process used to
fabricate three-dimensional biodegradable polyester structures from particles prepared
via a supercritical route.
Keywords: supercritical carbon dioxide; polymer scaffold foam
1. Scaffolds and supercritical carbon dioxide
The key to tissue engineering is to replace diseased or damaged tissues with an
immunologically tolerant living/viable tissue that can grow with the patient
(Sachlos & Czernuszka 2003). This involves either growing in vitro a tissue for
transplantation or implanting all the necessary ingredients to create the tissue
in vivo. Although both approaches may appear very different, they have the same
requirements. These are:
(i) cells that will proliferate to create the tissue; these can be transplanted or
from the surrounding tissue;
(ii) growth factors that signal the cells to proliferate; and
(iii) a method of delivery and stabilizing the cells in the defects; the vehicle for
delivering cells is called a scaffold.
Scaffolds are crucial to tissue engineering strategies for a number of reasons; as
a three-dimensional structure they provide volume ﬁll, mechanical integrity and
a surface that can provide chemical and architectural guidance for regenerating
tissues (Goldstein & Moalli 2001). Research in this area has been dominated
by developing new scaffold materials and new scaffold fabrication techniques
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249 q 2005 The Royal Society(see Leong et al. 2003; Ma 2004 for review). Our research has focused on using
carbon dioxide gas as a porogen to create three-dimensional polymeric structures
that can be used as scaffolds.
Carbon dioxide gas above a critical temperature (TcZ304.1 K) and pressure
(PcZ73.8 bar) is said to be supercritical (ﬁgure 1). In this state the carbon
dioxide is neither a gas nor a liquid but has properties of both. This is clearly
demonstrated by the phase diagram in ﬁgure 1; changing the temperature and
pressure changes the phase from solid to liquid to gas. However, at the critical
point (the intersection of Tc and Pc), the distinction between the liquid and gas
phases disappears. The single ﬂuid phase CO2 at this point (ﬁgure 1b(iii)) is said
to be supercritical. Supercritical carbon dioxide (scCO2) is an attractive solvent
for polymer processing, as it is inexpensive, non-toxic, non-ﬂammable and its
properties can be tuned through its density (Woods et al. 2004).M o r e
importantly, however, is the observation that some polymers when processed
in scCO2 swell to create porous materials. This swelling or foaming is due to
scCO2 being soluble in the polymers (see Cooper 2000 for review). The diffusion
of scCO2 into a polymer matrix separates the polymer chains and lowers their
resistance to chain rotation; this is called plasticization. The plasticization of
polymers by scCO2 results in a depression of the glass transition temperature
(Tg). For example, the Tg of PMMA was found to be reduced to near room
temperature at 12–15 wt% of CO2 absorbed (Goel & Beckman 1994a).
While in this highly plasticized state, the solubility of the gas in the polymer can
be decreased by reducing the CO2 gas pressure to atmospheric pressure (Goel &
Beckman 1994a). This drop in pressure is responsible for the occurrence of two
physical events. First the sudden reduction in pressure leads to a decrease in the
solubility of the gas in the polymer and this generates nuclei (or bubbles). These
nuclei grow to form the pores in the foam. The porous structures become ﬁxed by
thesecondevent.AsCO2leavesthepolymertheTgbeginstoriseagain,eventually
reachingatemperatureclosetothefoamingequipment.Thepolymerthenbecomes
glassy(vitriﬁcation)andtheporescangrownofurtherandaresaidtobe‘lockedin’
(Goel & Beckman 1994a; Mooney et al. 1996; Arora et al. 1998; Cooper 2000).
Nucleation (as described earlier) is usually accompanied with and competes
with the diffusion of gas into pores. This diffusion of gas into pores results in pore
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Figure 1. (a) Phase diagram for carbon dioxide, showing critical point and supercritical region
(McHugh & Krukonis 1994). (b) A practical demonstration showing the creation of the single
supercritical ﬂuid phase (image (iii)) by taking liquid CO2 above its critical temperature and
pressure (images (i) and (ii)); with subsequent lowering of temperature (and hence pressure) the
process is reversed (images (iv) and (v)) (Quirk et al. 2004; Howdle 2004).
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large number of nucleation sites. Each pore will develop so fast that the diffusion
effects will be negligible and the resultant structure will have a homogeneous or
uniform pore size distribution. On the other hand, if nucleation is very slow, the
pores nucleated ﬁrst will be signiﬁcantly larger than others due to greater
diffusion of gas from the surrounding matrix, and the resultant structure would
have wide dispersion in pore size (Alavi et al. 1999). Being able to control these
two events is important in creating scaffolds suitable for tissue engineering and
has been demonstrated by using different gases (CO2,N 2 and He), changing the
molecular weight of the polymer and manipulating processing conditions such as
temperature, pressure and venting rate (Goel & Beckman 1994a,b; Park et al.
1995; Arora et al. 1998; Sheridan et al. 2000; Howdle et al. 2001).
The depression of the polymer Tg has been captured in situ using a view cell
(ﬁgure 2). The outcome of plasticization can be different in that some polymers
such as the methacrylate-based glassy polymers (§2a) retain their structural
integrity under supercritical conditions, while others such as poly(D,L-lactide)
form a polymer/gas solution (§2b). We have prepared scaffolds from both
polymer types.
2. Tetrahydrofurfuryl methacrylate scaffolds
The heterocyclic, tetrahydrofurfuryl methacrylate (THFMA) has been shown to
have some intriguing properties. It is a methacrylate with a large pendent group
that has good miscibility with other polymeric systems, which is thought to be
due to the presence of additional moieties such as the ether oxygen atoms in the
pendent groups (Lee et al. 1992).
When blended with poly(ethyl methacrylate) (PEMA), a glassy semi-
interpenetrating network is formed that exhibits both low shrinkage and a low
exotherm on polymerization, as well as a low glass transition temperature
compared to other methacrylates (Patel et al. 1987). More interestingly,
however, PEMA/THFMA blends have been shown to remain rigid over a long
time period, while having a high water uptake (more than 70 wt% in 3 years;
Hutcheon et al. 1998). The water uptake behaviour is composed of two stages, an
initial rapid Fickian controlled stage that is followed by a long-term slow rate of
uptake, which is dominated by a clustering effect (Riggs et al. 1999a). This
anomalous uptake behaviour, which is dependent on the osmolarity of the
external solution (Sawtell et al. 1997), has been attributed to the THFMA
component in the composition (Patel et al. 2001a).
Blend systems formed by mixing THFMA with an isoprene–styrene copolymer
elastomer (SIS) are currently being evaluated for soft prosthetic applications
(Nazhat et al. 2001). The mechanical properties of these materials can be tailored
by altering the composition of the SIS and THFMA in the blend. These
compositions also demonstrate a two-stage water uptake, attributable to the
THFMA component of the blend (Nazhat et al. 2001).
(a) PEMA/THFMA
Bhusate & Braden were ﬁrst to describe a methacrylate polymer system that
involved the mixing of a powdered polymer constituent (PEMA) that initiates
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& Braden 1985). Residual benzoyl peroxide initiator, still present in the PEMA,
reacts with a tertiary amine (N,N-dimethyl-p-toluidine), resulting in the
formation of free radicals, capable of initiating polymerization of the THFMA
monomer (Bhusate & Braden 1985; Riggs et al. 2000). Thus far PEMA/THFMA
solid
solid
liquid
powder
foam
foam
before supercritical processing
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during supercritical processing–plasticization
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Figure 2. The in situ plasticization and foaming of amorphous polymers. Images are taken through
a high-pressure vessel with a sapphire window. This plasticization and foaming can occur via two
routes. The ﬁrst route is shown in images (a)–(c), the polymer, although plasticized, remains
structurally unchanged until nearly all the carbon dioxide gas has been vented and then the
polymer foams. In these images, the internal diameter of the vessel has been restricted by the
incorporation of a graduated scale (mm markings) (Barry et al. in press a). The second route is
shown in images (d)–(f), the polymer powder is plasticized forming a polymer gas solution which
foams when all the carbon dioxide gas has been vented (Quirk et al. 2004).
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drug release (Pearson et al. 1986; Di Silvio et al. 1994; Patel et al. 1998, 2001b;
Riggs et al. 1999b, 2000; Di Silvio et al. 2002) and also in the repair of bone and
cartilage (Patel & Braden 1991a–c; Downes et al. 1994; Reissis et al. 1994a,b).
Previously, the potential of this polymer system in cartilage repair had been
described for two-dimensional surfaces both in vivo and in vitro. Changing the
PEMA/THFMA from a two-dimensional surface to a three-dimensional
structure (ﬁgure 3) appeared to further enhance the phenotypic maintenance
of chondrocytes as indicated by the rounded cell morphology and increased
extracellular matrix proteins of articular cartilage (i.e. collagen type II,
chondroitin 4-sulphate and chondroitin 6-sulphate; Barry et al. 2004). Initial
attempts at foaming PEMA/THFMA produced highly porous foams but we were
unable to demonstrate connectivity between the pores in the foams. Thus, the
emphasis of this work changed and centred on modifying the supercritical
processing in order to provide adequate porosity, pore size, pore connectivity and
mechanical strength for tissue engineering purposes. This was achieved by
decreasing the venting rate.
chondrocytes on the unfoamed polymer discs
at day 4
chondrocytes on the unfoamed polymer discs
at day 8. Spread cells on flat surface (arrows)
chondrocytes on polymer discs foamed for
30 min, at day 8. Spread cells on flat
surface above pore (black arrows). Found
cells in pore (white arrow)
chondrocytes on the polymer discs foamed
for 30 min, at day 4
10 µm 10 µm
10 µm 10 µm
(a) (b)
(c) (d)
Figure 3. Chondrocytes growing on the unfoamed (a,c) and foamed (b,d) PEMA/THFMA
substrates. From Barry et al. (2004).
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pores while also allowing the pores to coalesce, thereby altering pore size and
interconnectivity (Barry et al. in press a). When applied to the PEMA/THFMA
scaffolds, the decrease in depressurization rate resulted in highly interconnected
porous structures, with mean pore sizes ranging from 100 to 450 mm (measured
by SEM). There was, however, an upper limit to these changes in pore
architecture beyond which no further beneﬁt can be seen. When this limit is
exceeded the pore sizes and mechanical strengths make them unsuitable for use
as scaffolds (Barry et al. in press a).
This study also highlighted the problems in applying individual techniques to
measure the pore size, porosity and interconnectivity (Barry et al. in press a).
For example, while SEM and micro-computed tomography (micro-CT) imaging
produced similar results for pore size and pore size distribution, mercury
intrusion porosimetry (MIP) generated results that were signiﬁcantly different.
To compensate for this a combination of techniques was applied in order to
adequately describe the key characteristics of the scaffolds produced. These
techniques include SEM, micro-CT, MIP and helium pycnometry (ﬁgure 4).
(b) SIS/THFMA
The foaming of PEMA/THFMA monoliths leads to a decrease in compliance
and ductility, resulting in very brittle scaffolds. As many of the characteristics of
the PEMA/THFMA system were attributable to the poly (THFMA) portion an
alternative polymeric system based on THFMA was sought. A previous study
has investigated the blending of THFMA with an isoprene–styrene copolymer
elastomer (SIS) for soft prosthetic applications (Nazhat et al. 2001). SIS is an
elastomer consisting of ordered block copolymers and has mechanical properties
similar to vulcanized natural rubber (Barry et al. in press b). SIS/THFMA blends
produce materials with mechanical properties that are either predominantly
plastic or elastomeric whereas the anomalous water uptake behaviour of poly
(THFMA) remains unchanged (Barry et al. in press b).
ScCO2 was successfully used to foam differing compositions of SIS/THFMA
without compromising the materials compliance (ﬁgure 5). The swelling of the
SIS/THFMA blend was similar to that of ﬁgure 2a–c in that the monoliths
Figure 4. Micro-CT images of scaffolds processed at different rates. (a) Rapid depressurization (30 s
for 100 bar to ambient pressure). (b) Slow depressurization (60 min for 100 bar to ambient
pressure). Changes in porosity, pore size and interconnectivity are clearly visible from the images.
Images from Barry et al. (in press a).
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had been vented from the high-pressure vessel. However, 24 h after the
processing, slight contraction of the foams could be seen. The greater the SIS
content in the blend, the smaller the foam that was produced. Similarly, pore
size, porosity and interconnectivity all decreased with increasing concentrations
of SIS. At low compositions of the SIS, highly porous, interconnected scaffolds
(ﬁgure 5, inset) with mechanical properties that closely match those of cartilage
could be produced (Barry et al. in press b). Subsequent work has shown that
these materials like the PEMA/THFMA provide a favourable substrate for
chondrocyte attachment and growth.
3. Polyester scaffolds
We have utilized scCO2 to create polyester scaffolds (e.g. PLLA, PDLLA, PGA
and PLGA) by two methods; the ﬁrst method is the preparation of PLA
monoliths as shown in ﬁgure 2d–f.
(a) PLA monoliths
Gas foaming of polyesters was ﬁrst described in De Ponti et al. (1991) and was
subsequently followed by the processing of either compressed polyester pellets or
solvent cast discs for prolonged periods of time under conditions that are near
critical (55 bar at 20–23 8C for 72 h; Mooney et al. 1996). Although mistakenly
reported as a method that utilizes scCO2 (Hutmacher 2000), the prolonged
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Figure 5. Compressive stress–strain behaviour for SIS/THFMA blend. For comparison,
PEMA/THFMA prepared by the same protocol is included. It can be seen that the behaviour of
these materials following compression is very different. Damage to the PEMA/THFMA foams
occurs at the onset of the plateau and results in densiﬁcation and ultimately the complete
destruction of the foam. This is not the case for the SIS/THFMA, whereby removal of the stress
allows the recovery of the material. Inset; electron micrographs of a foamed SIS/THFMA
(30%/70%) disc. From Barry et al. (in press b).
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polymeric foams were generated. The foams had pores of 100 mm diameter and
porosities up to 93%. Foams produced by this method were found to have low
connectivity and a non-porous skin which is formed by rapid loss of CO2 from the
edge (Goel & Beckman 1994b; Mooney et al. 1996). The combination of the gas
foaming with NaCl particulate leaching did lead to a highly interconnected void
network (Sheridan et al. 2000; Murphy et al. 2002). Control of the porosity and
pore size could be achieved by varying the particle/polymer ratio and salt crystal
size (Harris et al. 1998). Scaffolds fabricated by the combination of gas foaming/
salt leaching have been employed both for the controlled delivery of proteins and
as a support for the three-dimensional culture of cells (Quirk et al. 2004). One
drawback of the salt leaching step is that it can remove a large percentage of the
bioactive ingredients loaded in the scaffolds (Hutmacher 2000).
By contrast processing of polyester powders using scCO2 has allowed
preparation of highly porous, interconnected monoliths in a single step process.
As with the methacrylate scaffolds the pore architecture can be modiﬁed by
temperature, pressure and vent rate (ﬁgure 6; Howdle et al. 2001). The beneﬁt of
this approach is that it allows the incorporation of heat sensitive pharmaceuticals
and biological agents into the polyester foams, without loss of the active
agents due to the leaching step (Hutmacher 2000). The enzymes ribonuclease
scPLA scaffolds
Teflon mould
1mm
500 µm 500 µm
(a)( b)
(c)( d)
Figure 6. PLA scaffolds. (a) The scaffolds as fabricated and removed from the Teﬂon mould.
(b) Micro-CT images of the scaffolds, and (c,d) SEM images demonstrating that variation of
temperature, pressure and venting rate leads to scaffolds with different pore architectures.
From Quirk et al. (2004).
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with only negligible loss in biological activity (Howdle et al. 2001).
The technique is widely applicable and has been shown to allow the controlled
addition of very low concentrations of bioactive guest (Watson et al. 2002).
Moreover, the ﬁne control of morphology (ﬁgure 6) leads to applications as an
effective material for bone regeneration. Recent collaborative experiments
demonstrate bone formation due to the release of the osteoinductive protein
bone morphogenetic factor 2 (BMP-2) from PDLLA scaffold both in vitro and
in vivo (Yang et al. 2001a, Yang et al. 2003a,b). These scaffolds have further been
used to study adenoviral gene transfer into primary human bone marrow
osteoprogenitor cells (Partridge et al. 2002; Howard et al. 2002). Recently, it has
been demonstrated that the surfaces of these scCO2 prepared scaffolds can be
made more adhesive by plasma deposition of a ﬁne layer of poly(allylamine).
This was achieved without changing the bulk characteristics of the polymer and
signiﬁcantly increased cell attachment on the otherwise hydrophobic materials
(Barry et al. 2005).
(b) Particle generation
The formation of a polymer/gas solution by supercritically plasticized
polymers is seen in ﬁgure 2e. If this solution is forced through a nozzle during
depressurization, ﬁne microparticles can be fabricated (ﬁgure 7a,b; Hao et al.
2004). The size and shape of these microparticles can be ﬁnely controlled by
altering the nozzle diameter, the saturation temperature or ﬁlling the collecting
chamber with N2 gas. The N2 backpressure dynamically regulates the loss of CO2
from the issuing polymer/CO2 mixture (Hao et al. 2004).
These particles can be used in drug delivery as temperature and solvent labile
molecules can be mixed efﬁciently into the liqueﬁed polymer. This liqueﬁed
polymer/drug/CO2 mixture can then be sprayed into a collecting chamber, and
during this process particles of drug-loaded polymer are formed, which can be
used for drug delivery (Whitaker et al. 2005). Growth factor loaded
microparticles such as these are also ﬁnding applications as injectable scaffolds
that can be delivered to speciﬁc sites within the body for cell and tissue repair
(Salem et al. 2003).
Recently, these microparticles have been used to fabricate scaffolds using a
novel Surface Selective Laser Sintering (SSLS) process (ﬁgure 7c; Antonov et al.
2005). In conventional SLS, volumetric absorption of the laser radiation by
polymer leads to melting of the whole particles followed by their fusion. Exposure
of the polymer powders to high temperatures is prohibitive to many thermoliable
materials. In SSLS, this particle fusion can be limited to just the surfaces of each
particle. This is achieved by use of near infrared (ca 1 mm) laser wavelength,
which is not absorbed by the polymer and by the addition of a small amount (less
than 0.1 wt%) of carbon microparticles. The carbon microparticles are strong
absorbers of the laser radiation, hence they cause heating of only the surfaces of
each polymer particle. Thus, each particle fuses with its neighbour, but without
overheating and or collapse of the particle structure. This method therefore
facilitates the sintering of polymers that were previously unsuitable for SLS. For
example, PDLLA can now be used to fabricate complex three-dimensional
structures such as scaffolds (ﬁgure 7d). Additionally, if the particles are ﬁrst
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allows the fabrication of bioactive/biodegradable scaffolds in which the pore sizes
and porosity, connectivity and orientation of the pores can be ﬁnely controlled
(Antonov et al. 2005). Moreover, because there is only surface heating of the
particles, the SLS process allows retention of the activity of the bioactive. This
has been demonstrated (Antonov et al. 2005) by the encapsulation of a model
protein, (ribonuclease A) into particles of poly(D,L-lactic) acid (PLA) and the
fabrication of three-dimensional scaffolds via SLS.
4. Conclusion
This paper has brieﬂy reviewed some of the recent progress made in the use of
supercritical ﬂuids to process polymers into three-dimensional tissue engineering
scaffolds. It has described the plasticization and foaming of hydrophilic
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Figure 7. (a) Schematic diagram for the supercritical ﬂuid apparatus used to prepare PDLLA
particles: A, CO2 cylinder; B, nitrogen cylinder; C, CO2 feed pump; D, valves; E, mixing vessel; F,
collecting chamber; G, pressure gauges; H, thermocouple; I, backpressure regulator; J, cooling
device; K, spraying (ball) valve; L, cone nozzle (Hao et al. 2004). (b) SEM images of P(DLLA)
particles (Whitaker et al. 2005). (c) Schematic diagram of experimental SLS set-up. 1, diode laser;
2, quartz ﬁbre; 3, X–Y plotter; 4, polymer powder; 5, powder container with precision elevator
piston (Z-axis) (Antonov et al. 2005). (d) PLA scaffold made using the sintering process described
in text.
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the pore architecture in these scaffolds is achieved by altering the foaming
conditions as has been shown also for the polyester scaffolds.
For polyesters, the polymer viscosity is lower dramatically, leading to efﬁcient
mixing of bioactive materials and fabrication of three-dimensional scaffolds,
which can be used to enhance tissue regeneration. The same methodology can be
adapted to prepare particles of biodegradable polymer also loaded with bioactive
molecules. Such particles have proved to be very effective in a surface selective
laser sintering process leading to novel three-dimensional scaffolds with precise
shape and porosity. In all of these cases, the use of scCO2 provides a clean and
extremely effective route to novel three-dimensional scaffolds that would be
difﬁcult or impossible to fabricate through more conventional technologies.
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